The Rapid Quantitative Tear Test for MMP-9 from
Contact:
Tel: +1 858-923-4422
Email: info@aximbiotech.com
(C) 2023 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0105 USD | -11.27% | -8.70% | -44.74% |
16/04 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/03 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
The Rapid Quantitative Tear Test for MMP-9 from
Contact:
Tel: +1 858-923-4422
Email: info@aximbiotech.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-44.74% | 2.92M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.45% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |